Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 44: 2377, 1998;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zoppi, F.
Right arrow Articles by Maher, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoppi, F.
Right arrow Articles by Maher, K.
(Clinical Chemistry. 1998;44:2377.)
© 1998 American Association for Clinical Chemistry, Inc.


Letters

Screening Assay for Ethylene Glycol in Serum

Francesco Zoppi

Laboratorio di Biochimica Clinica ed Ematologia, Ospedale Niguarda Ca' Granda, Piazza Ospedale Maggiore 3, 20162 Milan, Italy, Fax 39-2-64442901 E-mail marta.melotti{at}galactica.it


To the Editor:

The recent paper by Eder et al. (1) recalls, among other things, the problems that a clinical STAT laboratory has to face in the case of ethylene glycol poisoning. As an alternative to the precise and accurate gas chromatographic technique, the enzymatic assay with glycerol dehydrogenase (EC 1.1.1.6) and NADH as tracer has been proposed by various authors [see, e.g., (2)(3)(4)]. The relative nonspecificity of glycerol dehydrogenase from Enterobacter aerogenes toward diols and triols allows interference with this test by propylene glycol, glycerol, 1,2-butanediol, and 2,3-butanediol (2)(5)(6). Nonetheless, its usefulness in emergency screening for ethylene glycol has been stressed, particularly for its technical simplicity (2).

Rynder et al. (2) used an analyzer, the Du Pont aca® SX (presently distributed by Dade Behring Inc., Deerfield, IL), that is particularly suited for emergency situations. Presently this instrument, together with the more recent version, the aca STAR, is still widely used in laboratories both in this country and in the United States. Unfortunately, the product that, following the method of Rynder et al., we were using to avoid interference from endogenous triacylglycerols and glycerol (triglyceride test kit for Monarch, cat. no. 35190, Instrumentation Laboratory) is no longer available in our country.

Because skilled personnel are not available at all times in our emergency laboratory and because cases of ethylene glycol poisoning are infrequent but not uncommon, I decided to continue to use the aca method whenever the gas chromatographic technique was not available. The modification I make is trivial: I cut compartment no. 2 (ingredients: lipase and stabilizers) of the aca triglyceride analytical test pack (Du Pont, cat. no. 702230901), wash it with deionized water, and firmly reseal the hole with transparent adhesive tape. I calibrate the test with a 16 mmol/L solution of ethylene glycol in pooled sera that are free of ethylene glycol, as assessed by gas chromatographic analysis, and use the same pooled sera as a blank. Linearity was studied by serial dilutions of the calibrator in ethylene glycol-free pooled sera down to the concentration of 1.6 mmol/L. The linear regression analysis of the results gave the following statistics: dose = 0.955 x response - 0.04 mmol/L, n = 10, r = 0.995, Sy||x = 0.41 mmol/L. The test is recalibrated every month.

In our laboratory, we are aware that the results obtained in this way need cautious interpretation and gas chromatographic confirmation; however, this test permits us to screen economically for ethylene glycol with a typical turnaround time <30 min.


References

  1. Eder AF, McGrath CM, Dowdy YG, Tomaszewski JE, Rosemberg FM, Wilson RB. Ethylene glycol poisoning: toxicokinetic and analytical factors affecting laboratory diagnosis. Clin Chem 1998;44:168-177.[Abstract/Free Full Text]
  2. Rynder KW, Glick MR, Jackson SA. Emergency screening for ethylene glycol in serum. Clin Chem 1986;32:1574-1577.[Abstract/Free Full Text]
  3. Hansonn P, Masson P. Simple enzymatic screening assay for ethylene glycol (ethan-1,2-diol) in serum. Clin Chim Acta 1989;182:95-102.[Web of Science][Medline] [Order article via Infotrieve]
  4. Standerfer J, Blackwell W. Enzymatic method for measuring ethylene glycol with a centrifugal analyzer. Clin Chem 1991;37:1734-1736.[Abstract/Free Full Text]
  5. Nilsson L, Jones AW. 2,3-Butanediol: a potential interfering substance in the assay of ethylene glycol by an enzymatic method. Clin Chim Acta 1992;208:225-229.[Web of Science][Medline] [Order article via Infotrieve]
  6. Malandain H, Cano Y. Interferences of glycerol, propylene glycol, and other diols in the enzymatic assay of ethylene glycol. Eur J Clin Chem Clin Biochem 1996;34:651-654.[Web of Science][Medline] [Order article via Infotrieve]

The Director of Regulatory Affairs and Quality Assurance for the Dade Behring Chemistry Group replies:

Kay Maher

Chemistry Group, Dade Behring, Newark, DE 19714-6101, Fax 302-631-6299


To the Editor:

As manufacturer of the aca® discrete clinical analyzer and the TGL test pack described in this Letter to the Editor, Dade Behring appreciates the opportunity to comment. As described in our labeling, the intended use of the TGL test pack is to measure quantitatively the triglycerides in serum. Dade Behring cannot support non-standard use of the TGL test pack for ethylene glycol testing because the TGL test pack has not been optimized for this use. Furthermore, because we have not filed a premarket notification with the US Food and Drug Administration for use of TGL test packs in ethylene glycol testing, we are restricted from promoting or endorsing the product for this use.




The following articles in journals at HighWire Press have cited this article:


Home page
HeartHome page
C L Hu, Y B Li, Y G Zou, J M Zhang, J B Chen, J Liu, Y H Tang, Q Z Tang, and C X Huang
Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy
Heart, April 1, 2007; 93(4): 488 - 490.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P James, C J Ellis, R M L Whitlock, A R McNeil, J Henley, and N E Anderson
Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study
BMJ, June 3, 2000; 320(7248): 1502 - 1504.
[Abstract] [Full Text]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zoppi, F.
Right arrow Articles by Maher, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zoppi, F.
Right arrow Articles by Maher, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS